TTY BIOPHARM COMPANY LIMITED

Ajouter à une liste

Communiqués TTY Biopharm Company Limited

Actions

4105

TW0004105002

Produits pharmaceutiques

Cours en clôture Taipei Exchange 30/09/2026			Varia. 5j.	Varia. 1 janv.
78,50 ^TWD	-0,38%		-0,63%	-3,68%

05/08	TTY Biopharm Company Limited publie ses résultats pour le deuxième trimestre et le premier semestre clos le 30 juin 2026	CI
06/05	TTY Biopharm Company Limited publie ses résultats pour le premier trimestre clos le 31 mars 2026	CI

Communiqués

11/08/22	TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in July 2022	PU
05/08/22	TTY Biopharm : Announcement of the consolidated financial report for the second quarter of year 2022	PU
02/08/22	TTY Biopharm : To clarify report of China Times, Commercial Times and Economic Daily News on Aug 02, 2022	PU
11/07/22	TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in June 2022	PU
01/07/22	TTY Biopharm : Announcement of the record date of cash dividend.	PU
13/06/22	TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in May 2022	PU
26/05/22	TTY Biopharm : To announce the Company received milestone from global pharmaceutical company for co-development overseas market of long-lasting microsphere drug.	PU
26/05/22	TTY Biopharm : Important resolutions of the Company's 2022 Annual General Meeting	PU
13/04/22	TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in Mar 2022	PU
31/03/22	TTY Biopharm : Announcement of TTY Biopharm's committee member of Remuneration committee resignation	PU
25/03/22	TTY Biopharm : The Company was invited by Fubon Securities to participate the on-line investors' conference.	PU
11/03/22	TTY Biopharm : Announcement of TTY Biopharm's unaudited income information in Feb 2022	PU
09/03/22	TTY Biopharm : Announcement of Year 2022 Annual General Meeting	PU
09/03/22	TTY Biopharm : To announce the change of General Manager	PU
09/03/22	TTY Biopharm : Announcement of the financial report for the year of 2021	PU
09/03/22	TTY Biopharm : Board of Directors proposed dividend distribution	PU
03/02/20	TTY : Biopharm Co Ltd. - TS-1 Capsule received TW NHI approval for Treatment of Patients with Locally Advanced or Metastatic Non-small Cell Lung Cancer	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Articles Zonebourse Analyses Zonebourse

Filtres

Les meilleurs outils réservés aux abonnés pour augmenter la performance de vos investissements !